Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Nov;70(3):429–442. doi: 10.1111/j.1476-5381.1980.tb08721.x

Effects of RMI 12330A, a new inhibitor of adenylate cyclase on myocardial function and subcellular activity.

G Grupp, I L Grupp, C L Johnson, M A Matlib, W Rouslin, A Schwartz, E T Wallick, T Wang, P Wisler
PMCID: PMC2044352  PMID: 6254599

Abstract

1 RMI 12330A, a lactam-imine, at concentrations of 10(-4) M and higher, inhibited basal as well as isoprenaline and NaF-stimulated adenylate cyclase activity of guinea-pig heart homogenates. However, RMI 12330A was a more potent inhibitor of histamine-stimulated adenylate cyclase (IC50 of 1.5 X 10(-5) M). 2 In the isolated work-performing heart of the guinea-pig, RMI 12330A (IC50 of 1.1 X 10(-6) M) depressed all cardiac functions: pressures developed, dP/dt, contractile force, dF/dt, work performance and stroke work. Left atrial pressure rose and the positive inotropic response to increasing heart rate (staircase) became negative. Histamine, isoprenaline and ouabain no longer caused positive inotropic effects. 3 Increasing the perfusate calcium concentration from 2.5 mM to 4.5 and 6.5 mM completely restored cardiac function after its depression by RMI 12330A. 4 RMI 12330A uncoupled mitochondrial oxidative phosphorylation; the classical uncoupler, dinitrophenol, had the same effects on cardiac dynamics as RMI 12330A. 5 RMI in high doses inhibited hydrolytic activity of Na+, K+-ATPase of crude and purified heart preparations (IC50 of 1.7 X 10(-4) M) and inhibited ouabain binding to the same enzymes (IC50 of 1.5 X 10(-4) M). 6 A lactam-imine analogue of RMI 12330A that had no effect on adenylate cyclase, was also without effect on any of the systems examined.

Full text

PDF
429

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BONTING S. L., SIMON K. A., HAWKINS N. M. Studies on sodium-potassium-activated adenosine triphosphatase. I. Quantitative distribution in several tissues of the cat. Arch Biochem Biophys. 1961 Dec;95:416–423. doi: 10.1016/0003-9861(61)90170-9. [DOI] [PubMed] [Google Scholar]
  3. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  4. Gervais A., Lane L. K., Anner B. M., Lindenmayer G. E., Schwartz A. A possible molecular mechanism of the action of digitalis: ouabain action on calcium binding to sites associated with a purified sodium-potassium-activated adenosine triphosphatase from kidney. Circ Res. 1977 Jan;40(1):8–14. doi: 10.1161/01.res.40.1.8. [DOI] [PubMed] [Google Scholar]
  5. Guellaen G., Mahu J. L., Mavier P., Berthelot P., Hanoune J. RMI 12330 A, an inhibitor of adenylate cyclase in rat liver. Biochim Biophys Acta. 1977 Oct 13;484(2):465–475. doi: 10.1016/0005-2744(77)90102-4. [DOI] [PubMed] [Google Scholar]
  6. Harigaya S., Schwartz A. Rate of calcium binding and uptake in normal animal and failing human cardiac muscle. Membrane vesicles (relaxing system) and mitochondria. Circ Res. 1969 Dec;25(6):781–794. doi: 10.1161/01.res.25.6.781. [DOI] [PubMed] [Google Scholar]
  7. Himms-Hagen J. Adrenergic receptors for metabolic responses in adipose tissue. Fed Proc. 1970 Jul-Aug;29(4):1388–1401. [PubMed] [Google Scholar]
  8. Johnson C. L., Mizoguchi H. The interaction of histamine and guanylnucleotides with cardiac adenylate cyclase and its relationship to cardiac contractility. J Pharmacol Exp Ther. 1977 Jan;200(1):174–186. [PubMed] [Google Scholar]
  9. Johnson C. L., Weinstein H., Green J. P. Studies on histamine H2 receptors coupled to cardiac adenylate cyclase. Blockade by H2 and H1 receptor antagonists. Mol Pharmacol. 1979 Sep;16(2):417–428. [PubMed] [Google Scholar]
  10. Johnson C. L., Weinstein H., Green J. P. Studies on histamine H2 receptors coupled to cardiac adenylate cyclase. Effects of guanylnucleotides and structural requirements for agonist activity. Biochim Biophys Acta. 1979 Oct 4;587(2):155–168. doi: 10.1016/0304-4165(79)90350-7. [DOI] [PubMed] [Google Scholar]
  11. Kirchberger M. A., Tada M., Repke D. I., Katz A. M. Cyclic adenosine 3',5'-monophosphate-dependent protein kinase stimulation of calcium uptake by canine cardiac microsomes. J Mol Cell Cardiol. 1972 Dec;4(6):673–680. doi: 10.1016/0022-2828(72)90120-4. [DOI] [PubMed] [Google Scholar]
  12. Krause E. G., Will H., Schirpke B., Wollenberger A. Cyclic AMP-enhanced protein phosphorylation and calcium binding in a cell membrane-enriched fraction from myocardium. Adv Cyclic Nucleotide Res. 1975;5:473–490. [PubMed] [Google Scholar]
  13. LARDY H. A., WELLMAN H. The catalytic effect of 2,4-dinitrophenol on adenosinetriphosphate hydrolysis by cell particles and soluble enzymes. J Biol Chem. 1953 Mar;201(1):357–370. [PubMed] [Google Scholar]
  14. Lane L. K., Potter J. D., Collins J. H. Large-scale purification of Na,K-ATPase and its protein subunits from lamb kidney medulla. Prep Biochem. 1979;9(2):157–170. doi: 10.1080/00327487908061681. [DOI] [PubMed] [Google Scholar]
  15. Lelievre L., Paraf A., Charlemagne D., Sheppard J. R. Plasma membrane studies on drug sensitive and resistant cell lines. I. Cross resistance and membrane enzyme coordination (ouabain/cAMP/Na+/K+ ATPase/adenylate cyclase). Exp Cell Res. 1977 Jan;104(1):191–197. doi: 10.1016/0014-4827(77)90081-7. [DOI] [PubMed] [Google Scholar]
  16. Levey G. S., Lehotay D. C., Canterbury J. M., Bricker L. A., Meltz G. J. Isolation of a unique peptide inhibitor of hormone-responsive adenylate cyclase. J Biol Chem. 1975 Jul 25;250(14):5730–5733. [PubMed] [Google Scholar]
  17. Neely J. R., Liebermeister H., Battersby E. J., Morgan H. E. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol. 1967 Apr;212(4):804–814. doi: 10.1152/ajplegacy.1967.212.4.804. [DOI] [PubMed] [Google Scholar]
  18. Pitts B. J., Schwartz A. Improved purification and partial characterization of (Na+, K+)-ATPase from cardiac muscle. Biochim Biophys Acta. 1975 Aug 20;401(2):184–195. doi: 10.1016/0005-2736(75)90303-x. [DOI] [PubMed] [Google Scholar]
  19. Reuter H. Localization of beta adrenergic receptors, and effects of noradrenaline and cyclic nucleotides on action potentials, ionic currents and tension in mammalian cardiac muscle. J Physiol. 1974 Oct;242(2):429–451. doi: 10.1113/jphysiol.1974.sp010716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  21. Schwartz A., Endman M. L., Ezrailson E. G., Lehotay D. C., Leyey G. Possible cyclic nucleotide regulation of calcium mediating myocardial contraction. Science. 1977 Mar 11;195(4282):982, 989-90. doi: 10.1126/science.14399. [DOI] [PubMed] [Google Scholar]
  22. Schwartz A., Entman M. L., Kaniike K., Lane L. K., Van Winkle W. B., Bornet E. P. The rate of calcium uptake into sarcoplasmic reticulum of cardiac muscle and skeletal muscle. Effects of cyclic AMP-dependent protein kinase and phosphorylase b kinase. Biochim Biophys Acta. 1976 Feb 19;426(1):57–72. doi: 10.1016/0005-2736(76)90429-6. [DOI] [PubMed] [Google Scholar]
  23. Sumida M., Wang T., Mandel F., Froehlich J. P., Schwartz A. Transient kinetics of Ca2+ transport of sarcoplasmic reticulum. A comparison of cardiac and skeletal muscle. J Biol Chem. 1978 Dec 25;253(24):8772–8777. [PubMed] [Google Scholar]
  24. Verma S. C., McNeill J. H. Cardiac histamine receptors: differences between left and right atria and right ventricle. J Pharmacol Exp Ther. 1977 Feb;200(2):352–362. [PubMed] [Google Scholar]
  25. Wallick E. T., Anner B. M., Ray M. V., Schwartz A. Effect of temperature on phosphorylation and ouabain binding to N-ethylmaleimide-treated (Na+, K+)-ATPase. J Biol Chem. 1978 Dec 25;253(24):8778–8786. [PubMed] [Google Scholar]
  26. Wiester M. J., Bonventre P. F., Grupp G. Estimate of myocardial damage induced by diphtheria toxin. J Lab Clin Med. 1973 Mar;81(3):354–364. [PubMed] [Google Scholar]
  27. Wollenberger A., Babskii E. B., Krause E. G., Genz S., Blohm D., Bogdanova E. V. Cyclic changes in levels of cyclic AMP and cyclic GMP in frog myocardium during the cardiac cycle. Biochem Biophys Res Commun. 1973 Nov 16;55(2):446–452. doi: 10.1016/0006-291x(73)91107-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES